Modafinil
Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting medication used primarily to treat narcolepsy. Modafinil is also approved for stimulating wakefulness in people with sleep apnea and shift work sleep disorder. It is taken by mouth. Modafinil is subject to regulatory controls and age limits in some countries.
Clinical data | |
---|---|
Trade names | Provigil, Alertec, Modavigil, others |
Other names | CRL-40476; Diphenylmethyl-sulfinylacetamide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602016 |
License data | |
Pregnancy category |
|
Dependence liability | Relatively low |
Addiction liability | Low |
Routes of administration | By mouth |
Drug class | CNS stimulant eugeroic |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 62.3% |
Metabolism | Liver (primarily via amide hydrolysis); CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5 involved |
Elimination half-life | 12–15 h (modafinil, the racemic mixture), 15 h (armodafinil, the (R)-enantiomer), 4 h (esmodafinil, the (S)-enantiomer). |
Excretion | Urine (80%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.168.719 |
Chemical and physical data | |
Formula | C15H15NO2S |
Molar mass | 273.35 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Modafinil has potential for causing severe allergic reactions, mental (psychiatric) effects, hypersensitivity, adverse interactions with prescription drugs, and misuse or abuse. Modafinil may harm the fetus.
While modafinil is used as a cognitive enhancer or "smart drug" among healthy individuals seeking improved focus and productivity, its use outside medical supervision raises concerns regarding potential misuse or abuse. Research on the cognitive enhancement effects of modafinil in non-sleep-deprived individuals has yielded mixed results, with some studies suggesting modest improvements in attention and executive functions, while others show no significant benefits or even a decline in cognitive functions.